NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | | | | Group enriched |
SH3GL3 | SH3-domain GRB2-like 3 | | | | | | Group enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
UNC5A | Unc-5 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |
ZIC2 | Zic family member 2 | Disease related genes Plasma proteins Transcription factors
| | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Group enriched |
PTCHD2 | Patched domain containing 2 | Predicted membrane proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
FAM163B | Family with sequence similarity 163, member B | Predicted membrane proteins
| | | | | Group enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NKAIN4 | Na+/K+ transporting ATPase interacting 4 | Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | | | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CDH20 | Cadherin 20, type 2 | Predicted membrane proteins
| | | | | Group enriched |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors
| | | | | Group enriched |
IGFL4 | IGF-like family member 4 | | | | | | Group enriched |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | | | | Group enriched |
MEGF11 | Multiple EGF-like-domains 11 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PABPC1L2B | Poly(A) binding protein, cytoplasmic 1-like 2B | | | | | | Group enriched |
SLC25A18 | Solute carrier family 25 (glutamate carrier), member 18 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM130 | Transmembrane protein 130 | Predicted membrane proteins
| | | | | Group enriched |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | | | | | Group enriched |
C14orf23 | Chromosome 14 open reading frame 23 | | | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
COL20A1 | Collagen, type XX, alpha 1 | Predicted secreted proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FBLL1 | Fibrillarin-like 1 | | | | | | Group enriched |
FUT9 | Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) | Predicted membrane proteins
| | | | | Group enriched |
HRK | Harakiri, BCL2 interacting protein (contains only BH3 domain) | Predicted membrane proteins
| | | | | Group enriched |
LHFPL5 | Lipoma HMGIC fusion partner-like 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
LPPR1 | Lipid phosphate phosphatase-related protein type 1 | Predicted membrane proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | Predicted membrane proteins
| | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
SPHKAP | SPHK1 interactor, AKAP domain containing | | | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | | | | Group enriched |
TMEFF2 | Transmembrane protein with EGF-like and two follistatin-like domains 2 | Predicted membrane proteins
| | | | | Group enriched |
ZFR2 | Zinc finger RNA binding protein 2 | | | | | | Group enriched |
BSN | Bassoon presynaptic cytomatrix protein | Plasma proteins
| | | | | Group enriched |